PUBLICACIONES


Bibliografía reciente de interés

Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. Peyvandi F, Scully M, Kremer Hovinga JA, Cataland S, Knöbl P, Wu H, et al; TITAN Investigators. N Engl J Med. 2016 Feb 11;374(6):511-22.

Blombery P, Kivivali L, Pepperell D, McQuilten Z, Engelbrecht S, Polizzotto Mnet al; TTP registry steering committee. Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first five years of the Australian TTP/Thrombotic Microangiopathy registry. Intern Med J. 2015 Oct 19. doi: 10.1111/imj.12935. [Epub ahead of print]   http://www.ncbi.nlm.nih.gov/pubmed/26477687

Tersteeg C, Verhenne S, Roose E, Schelpe AS, Deckmyn H, De Meyer SF et al. ADAMTS13 and anti-ADAMTS13 autoantibodies inthrombotic thrombocytopenic purpura- current perspectives and new treatment strategies. Expert Rev Hematol. 2015 Nov 18. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26581428

Toussaint-Hacquard M, Coppo P, Soudant M, Chevreux L, Mathieu-Nafissi S, Lecompte Tet al. Type of plasma preparation used for plasma exchange and clinical outcome of adult patients with acquired idiopathic thrombotic thrombocytopenic purpura: a French retrospective multicenter cohort study. Transfusion. 2015 Oct;55(10):2445-51. http://www.ncbi.nlm.nih.gov/pubmed/26173755

Delmas Y, Helou S, Chabanier P, Ryman A, Pelluard F, Carles D, et al. Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease. BMC Pregnancy Childbirth. 2015 Jun 17;15:137. http://www.ncbi.nlm.nih.gov/pubmed/26081109

Bittencourt CE, Ha JP, Maitta RW. Re-examination of 30-day survival and relapse rates in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. PLoS One. 2015 May 22;10(5):e0127744.http://www.ncbi.nlm.nih.gov/pubmed/26000799

Gavriilaki E, Yuan X, Ye Z, Ambinder AJ, Shanbhag SP, Streiff MB et al. Modified Ham test for atypical hemolytic uremic syndrome. Blood. 2015 Jun 4;125(23):3637-46http://www.ncbi.nlm.nih.gov/pubmed/25862562

Pérez-Rodríguez A, Lourés E, Rodríguez-Trillo Á, Costa-Pinto J, García-Rivero A, Batlle-López A et al. Inherited ADAMTS13 deficiency (Upshaw-Schulman syndrome): a short review. Thromb Res. 2014 Dec;134(6):1171-5. http://www.ncbi.nlm.nih.gov/pubmed/25242241

Pérez-Rodríguez A, Batlle-López A, Blanco R, Varela I, León J, Delgado MD  et al. A novel mutation in ADAMTS13 of a child with Upshaw-Schulman Syndrome. Thromb Haemost. 2014 Nov;112(5):1065-8.http://www.ncbi.nlm.nih.gov/pubmed/25057114

Artículos publicados por el Grupo de Estudio de la PTT.

Julio del Río-Garma, Javier de la Rubia, Iñigo Romón, José Antonio García-Erce, Enric Contreras, Cristina Arbona and Arturo Pereira. RE: Type of virus-securized plasma an treatment refractoriness in thrombotic thrombocytopenic purpura . [e-Letter], Blood. (http://www.bloodjournal.org/content/125/25/3860.e-letters). 2 September 2015. Accessed 3 September 2015

Julio del Río , Arturo Pereira , Javier de la Rubia , José Antonio García-Erce , Cristina Arbona , Enric Contreras and Miguel Lozano. RE: Platelet transfusion as a proxy for more severe thrombotic thrombocytopenic purpura.  [e-Letter], Blood.

(http://www.bloodjournal.org/content/125/9/1470.e-letters). 13 March 13 2015. Accessed March 25, 2015

Contreras E, de la Rubia J, Del Río-Garma J, Díaz-Ricart M, García-Gala JM, Lozano M; por el Grupo Español de Aféresis. Guía diagnóstica y terapéutica de las microangiopatías trombóticas del Grupo Español de Aféresis. Med Clin (Barc). 2015 Apr 8;144(7):331 http://www.ncbi.nlm.nih.gov/pubmed/25433791

De la Rubia J, Contreras E, del Río-Garma J. Púrpura trombótica trombocitopenica. Med Clin (Barc) 2011; 136(12) :534-540. http://www.ncbi.nlm.nih.gov/pubmed/25433791

de la Rubia J, Moscardó F, Gómez MJ, Guardia R, Rodríguez P, Sebrango A, et al. Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: results of a Spanish multicenter study. Transfus Apher Sci 2010;43:299-303. http://www.ncbi.nlm.nih.gov/pubmed/20934383

Álvarez-Larrán A, Río-Garma J, Pujol M, de la Rubia J, Hernández-Jodrá M, Borrell M, et al. Newly diagnosed versus relapsed idiopathic thrombotic thrombocytopenic purpura: a comparison of presenting clinical characteristics and response to treatment. Ann Hematol 2009;88:973-8. http://www.ncbi.nlm.nih.gov/pubmed/19205654

Río-Garma J, Álvarez-Larrán A, Martínez C, Muncunill J, Castellà D, de la Rubia J, et al. Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study. Br J Haematol 2008;143:39-45. http://www.ncbi.nlm.nih.gov/pubmed/18637799

Río-Garma J, Pereira A, Arroyo JL, Mateo J, Álvarez-Larrán A, Martínez C, Muncunill J, Barbolla L. ADAMTS-13 activity and von Willebrand factor levels in methylene-blue photo-inactivated plasma processed by either the Springe method or an ´in house´ system. Vox Sang 2008;95:101-5. http://www.ncbi.nlm.nih.gov/pubmed/18557825

Pereira A. Efficacy of different plasma sources in the treatment of thrombotic thrombocytopenic purpura. ISBT Science Series 2009; 4(1): 111-117.

Muncunill J. Thrombotic thrombocytopenic purpura (TTP): Is any plasma useful to treat the TTP?. ISBT Science Series 2007; 2(1): 233-239.


Guías Clínicas

Contreras E, de la Rubia J, Del Río-Garma J, Díaz-Ricart M, García-Gala JM, Lozano M; por el Grupo Español de Aféresis.  Guía diagnóstica y terapéutica de las microangiopatías trombóticas. Med Clin (Barc). 2015 Apr 8;144(7):331; http://www.ncbi.nlm.nih.gov/pubmed/25433791

De la Rubia J, Contreras E, del Río-Garma J. Púrpura trombótica trombocitopenica. Med Clin (Barc) 2011; 136(12) :534-540.    http://www.ncbi.nlm.nih.gov/pubmed/25433791

Scully M, Hunt BJ, Benjamin S, Liesner R, Rose P, Peyvandi F, et al; British Committee for Standards in Haematology. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol. 2012 Aug;158 (3):323-35    http://www.ncbi.nlm.nih.gov/pubmed/22624596

 

Publicaciones sobre PTT y MAT realizadas por los miembros del GEPTT antes / después de la constitución formal y por otros autores españoles.

Gainza E, Fernández S, Martínez D, Castro P, Bosch X, Ramírez Jet al. Pulmonary tumor thrombotic microangiopathy: report of 3 cases and review of the literature. Medicine (Baltimore). 2014 Nov;93(24):359-63. http://www.ncbi.nlm.nih.gov/pubmed/25500705

Pérez-Rodríguez A, Lourés E, Rodríguez-Trillo Á, Costa-Pinto J, García-Rivero A, Batlle-López A et al. Inherited ADAMTS13 deficiency (Upshaw-Schulman syndrome): a short review. Thromb Res. 2014 Dec;134(6):1171-5. http://www.ncbi.nlm.nih.gov/pubmed/25242241

Pérez-Rodríguez A, Batlle-López A, Blanco R, Varela I, León J, Delgado MD  et al. A novel mutation in ADAMTS13 of a child with Upshaw-Schulman Syndrome. Thromb Haemost. 2014 Nov;112(5):1065-8.http://www.ncbi.nlm.nih.gov/pubmed/25057114

Quintero V, Garcia-Pose A, Barrios-Tascon A, Pacheco-Cumani M. Congenital ADAMTS13 deficiency: a rare mimicker of immune thrombocytopenic purpura. J Pediatr Hematol Oncol. 2014 Nov;36(8):653-5.http://www.ncbi.nlm.nih.gov/pubmed/24942015

González-Mesa E, Narbona I, Blasco M, Cohen I. Unfavorable course in pregnancy-associated thrombotic thrombocytopenic purpura necessitating a perimortem Cesarean section: a case report. J Med Case Rep. 2013 Apr 29;7:119. http://www.ncbi.nlm.nih.gov/pubmed/23628258

Verdú J, Fernández P, Rivas C, Romero A, Soler S, Verdú JJ. Características clínico-biológicas de las púrpuras trombocitopénicas trombóticas tratadas entre los años 1983-2006 en el Hospital General Universitario de Alicante. Rev Clin Esp 2007 May;207(5):243-5. http://www.ncbi.nlm.nih.gov/pubmed/17504669

Alvarez-Larrán A, Del Río J, Ramírez C, Albo C, Peña F, Campos A, Cid J, Muncunill J, Sastre JL, Sanz C. Pereira A. Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Vox Sanguinis 2004; 86: 246-251. http://www.ncbi.nlm.nih.gov/pubmed/15144529

Castellá D, Pujol M, Juliá A, Massague I, Bueno J, Ramón Grifols J, Puig L. Thrombotic thrombocytopenic purpura and pregnancy: a review of ten cases. Vox Sang 2004; 87(4):287-90.http://www.ncbi.nlm.nih.gov/pubmed/15585025

Lozano M, Domingo A, Pereira A, Fontanals J, Mazzara R. Platelet transfusion in thrombotic thrombocytopenic purpura: between Scylla and Charybdis. Transfusion. 2005 Dec;45(12):1984.http://www.ncbi.nlm.nih.gov/pubmed/16371055

Alvarez-Larrán A, Petriz J, Martínez A, Sanz C, Pereira A. Plasma from patients with thrombotic thrombocytopenic purpura induces activation of human monocytes and polymorphonuclear neutrophils.  Br J Haematol 2003; 120(1):129-34. http://www.ncbi.nlm.nih.gov/pubmed/12492588

de la Rubia J, Plumé G, Arriaga F, Carpio N, Sanz MA, Marty ML. Platelet transfusion and thrombotic thrombocytopenic purpura. Transfusion 2002 Oct;42(10):1384-5. http://www.ncbi.nlm.nih.gov/pubmed/12423525

de la Rubia J, Arriaga F, Linares D, Larrea L, Carpio N, Marty ML, Sanz MA. Role of methylene blue-treated or fresh-frozen plasma in the response to plasma exchange in patients with thrombotic thrombocytopenic purpura. Br J Haematol 2001; 114:721-723. http://www.ncbi.nlm.nih.gov/pubmed/11553005

de la Rubia J, García I, Jarque I, Arriaga F, Gomis F, Sanz MA. Splenectomy in patients with refractory or relapsing thrombotic thrombocytopenic purpura. Haematologica 2000 Apr;85(4):440-1.http://www.ncbi.nlm.nih.gov/pubmed/10756380

de la Rubia J, López A, Arriaga F, Cid AR, Vicente AI, Marty ML, Sanz MA. Response to plasma exchange and steroids as combined therapy for patients with thrombotic thrombocytopenic purpura. Acta Haematol 1999;102(1):12-6. http://www.ncbi.nlm.nih.gov/pubmed/10473882

Blanco A, Palacio C, López A, Acebedo G, Castellá D, Juliá A. Púrpura trombótica trombocitopénica. Estudio restrospectivo de 22 episodios consecutivos en 16 pacientes Med Clin (Barc) 1998; 111(10):385-8.http://www.ncbi.nlm.nih.gov/pubmed/9833242

Pereira A, Mazzara R, Monteagudo J, Sanz C, Puig L, Martínez A, Ordinas A, Castillo R. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a multivariate analysis of factors predicting the response to plasma exchange. Ann Hematol 1995; 70(6):319-23. http://www.ncbi.nlm.nih.gov/pubmed/7632812

Pereira A, Monteagudo J, Bono A, Lopez-Guillermo A, Ordinas A. Effect of splenectomy on von Willebrand factor multimeric structure in thrombotic thrombocytopenic purpura refractory to plasma exchange. Blood Coagul Fibrinolysis. 1993;4(5):783-6. http://www.ncbi.nlm.nih.gov/pubmed/8292728

Monteagudo J, Pereira A, Reverter JC, Pijoan J, Tusell J, Puig L, Ordinas A, Castillo R. Thrombin generation and fibrinolysis in the thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Thromb Haemost 1991;66(5):515-9. http://www.ncbi.nlm.nih.gov/pubmed/1803613

Monteagudo J, Pereira A, Roig S, Reverter JC, Ordinas A, Castillo R. Investigation of plasma von Willebrand factor and circulating platelet aggregating activity in mitomycin C-related hemolytic-uremic syndrome. Am J Hematol 1990 Jan;33(1):46-9. http://www.ncbi.nlm.nih.gov/pubmed/2104558

Pereira A, Mazzara R, Sanz C, Monteagudo J, Puig L, Castillo R.. Síndromes trombóticos microangiopáticos del adulto: resultados del tratamiento con recambio plasmático. Med Clin (Barc) 1990; 95(4):133-6.http://www.ncbi.nlm.nih.gov/pubmed/2250532


v.20160321